CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV NASH-NAFLD
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
UEGW 2015     Banner2   IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
In binge Britain, health chiefs say any alcohol is risky
01-08-2016
J&J signs deal with Chinese company for hepatitis B drug
01-07-2016
Dynavax's hep B vaccine meets goals in late-stage study
01-07-2016
Fibrin sealant patch provides better hemostasis during liver resection
01-06-2016
View Complete News Library
 
 
View all Congresses
 
 
 
  Line  
  Featured Abstracts          
 
Direct-Acting Antiviral Agents for the Hepatitis C Virus-Infected Chronic Kidney Disease Population: The Dawn of a New Era
 
The expanding toolbox for hepatitis C virus research
 
Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison
 
Hepatitis C Virus in Children: Deferring Treatment in Expectation of Direct-Acting Antiviral Agents
 
Chronic hepatitis C virus infection, a new cardiovascular risk factor?
 
Hepatitis C genotype 4: The past, present, and future
 
 
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014
 
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France
 
Insomnia in Adults With Chronic Hepatitis B, Liver Failure, and Cirrhosis: A Case-
 
Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta-analysis
 
A low-cost, user-friendly EEG recording system for the assessment of hepatic encephalopathy
 
The why and wherefore of hepatic encephalopathy
 
 
In Patients with Cirrhosis, Driving Simulator Performance is Associated With Real-life Driving
 
Probiotics are Helpful in Hepatic Encephalopathy: A Meta-Analysis of Randomized Trials
 
A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment
 
Aspirin use is associated with lower indices of liver fibrosis among adults in the United States
 
Follow-up of patients with chronic hepatitis C and a sustained viral response
 
Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review
 
 
          View All Abstracts  
  Line  
                     
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
 
NASH/NAFLD
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
         
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2016 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.